Table 1.
Disease | Mechanisms | Observational studies | Clinical trials |
---|---|---|---|
Cancer | Effects on cells, angiogenesis, and metastasis10 | Breast and colorectal cancer incidence11; survival12 | Breast and all-cancer incidence13 |
CVD | Effects on serum cholesterol levels, arterial stiffness, insulin resistance, hyperglycemia, and increased incident metabolic syndrome are potentially plausible mediators8 | Refs.14,15 | Effect on CVD risk factors16 |
Dementia | Regulation of calcium homeostasis, clearance of amyloid-β peptide, antioxidant and anti-inflammatory effects, and possible protection against the neurodegenerative mechanisms associated with AD17 | Incidence18 | |
DM | Improves insulin sensitivity and secretion, mainly via its anti-inflammatory properties19 | Incidence20; meta-analysis21 | |
Falls and fractures | Reduces bone mass loss by reducing inflammation22; maintains cognition23; helps maintain muscle mass24 | Ref.25 | Ref.26 |
MS | Effects on regulatory T and B cells27 | Ref.28 | |
Respiratory infections | Induction of cathelicidin and defensins29; strengthens adaptive and innate immune system30 | Pneumonia31 | Influenza32,33; ARI34 |
AD, Alzheimer disease; ARI, acute respiratory tract infection; CVD, cardiovascular disease; DM, diabetes mellitus; MS, multiple sclerosis.